163 related articles for article (PubMed ID: 20388629)
1. Distinct patterns of kidney and liver cyst growth in pkd2(WS25/-) mice.
Doctor RB; Serkova NJ; Hasebroock KM; Zafar I; Edelstein CL
Nephrol Dial Transplant; 2010 Nov; 25(11):3496-504. PubMed ID: 20388629
[TBL] [Abstract][Full Text] [Related]
2. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease.
Masyuk TV; Radtke BN; Stroope AJ; Banales JM; Masyuk AI; Gradilone SA; Gajdos GB; Chandok N; Bakeberg JL; Ward CJ; Ritman EL; Kiyokawa H; LaRusso NF
Gastroenterology; 2012 Mar; 142(3):622-633.e4. PubMed ID: 22155366
[TBL] [Abstract][Full Text] [Related]
4. Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease.
Zhang M; Srichai MB; Zhao M; Chen J; Davis LS; Wu G; Breyer MD; Hao CM
Int J Med Sci; 2019; 16(1):180-188. PubMed ID: 30662341
[No Abstract] [Full Text] [Related]
5. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
6. CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.
Amura CR; Brodsky KS; Gitomer B; McFann K; Lazennec G; Nichols MT; Jani A; Schrier RW; Doctor RB
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C786-96. PubMed ID: 18199703
[TBL] [Abstract][Full Text] [Related]
7. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
8. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2
Monirujjaman M; Aukema HM
J Nephrol; 2019 Jun; 32(3):401-409. PubMed ID: 30671914
[TBL] [Abstract][Full Text] [Related]
10. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
[TBL] [Abstract][Full Text] [Related]
12. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
Bae KT; Zhou W; Shen C; Landsittel DP; Wu Z; Tao C; Chapman AB; Torres VE; Yu ASL; Mrug M; Bennett WM; Harris PC;
Clin J Am Soc Nephrol; 2019 Jun; 14(6):823-833. PubMed ID: 31088850
[TBL] [Abstract][Full Text] [Related]
13. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.
Li A; Tian X; Zhang X; Huang S; Ma Y; Wu D; Moeckel G; Somlo S; Wu G
Am J Pathol; 2015 Oct; 185(10):2843-60. PubMed ID: 26435415
[TBL] [Abstract][Full Text] [Related]
14. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.
Li A; Fan S; Xu Y; Meng J; Shen X; Mao J; Zhang L; Zhang X; Moeckel G; Wu D; Wu G; Liang C
J Cell Mol Med; 2017 Aug; 21(8):1619-1635. PubMed ID: 28244683
[TBL] [Abstract][Full Text] [Related]
16. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
[TBL] [Abstract][Full Text] [Related]
17. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
Wang X; Harris PC; Somlo S; Batlle D; Torres VE
Nephrol Dial Transplant; 2009 Feb; 24(2):526-34. PubMed ID: 18826972
[TBL] [Abstract][Full Text] [Related]
18. IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease.
Wang W; Pottorf TS; Wang HH; Dong R; Kavanaugh MA; Cornelius JT; Dennis KL; Apte U; Pritchard MT; Sharma M; Tran PV
J Pathol; 2021 Jul; 254(3):289-302. PubMed ID: 33900625
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
Wu G; Somlo S
Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
[TBL] [Abstract][Full Text] [Related]
20. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
